Shenzhen Hepalink Pharmaceutical Group Co., Ltd. announced the board has resolved not to declare a final dividend for the year ended 31 December 2023 (2022: RMB 1.0 per ten ordinary shares).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.22 CNY | +0.99% | -2.57% | -12.87% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.87% | 1.87B | |
+21.59% | 44.15B | |
+23.03% | 23.02B | |
+18.26% | 15.33B | |
+12.26% | 13.74B | |
+52.55% | 12.16B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.88% | 5.66B |
- Stock Market
- Equities
- 002399 Stock
- News Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Announces No Final Dividend for the Year Ended 31 December 2023